20930086

Source:http://linkedlifedata.com/resource/pubmed/id/20930086

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022671, umls-concept:C0031928, umls-concept:C0036043, umls-concept:C0162597, umls-concept:C0205210, umls-concept:C0439859, umls-concept:C1513143
pubmed:issue	2
pubmed:dateCreated	2011-2-17
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00752479
pubmed:abstractText	Mesenchymal stromal cells (MSCs) abrogate alloimmune response in vitro, suggesting a novel cell-based approach in transplantation. Moving this concept toward clinical application in organ transplantation should be critically assessed.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101271570
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1555-905X
pubmed:author	pubmed-author:CapelliChiaraC, pubmed-author:CasiraghiFedericaF, pubmed-author:CassisPaolaP, pubmed-author:CavinatoRegiane AparecidaRA, pubmed-author:CortinovisMonicaM, pubmed-author:GolayJoseeJ, pubmed-author:GottiElianaE, pubmed-author:IntronaMartinoM, pubmed-author:MarasàMaddalenaM, pubmed-author:NorisMarinaM, pubmed-author:PericoNorbertoN, pubmed-author:RambaldiAlessandroA, pubmed-author:RemuzziGiuseppeG, pubmed-author:RizzoPaolaP, pubmed-author:TodeschiniMartaM
pubmed:issnType	Electronic
pubmed:volume	6
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	412-22
pubmed:meshHeading	pubmed-meshheading:20930086-Adult, pubmed-meshheading:20930086-Biological Markers, pubmed-meshheading:20930086-Biopsy, pubmed-meshheading:20930086-CD8-Positive T-Lymphocytes, pubmed-meshheading:20930086-Cells, Cultured, pubmed-meshheading:20930086-Creatinine, pubmed-meshheading:20930086-Drug Therapy, Combination, pubmed-meshheading:20930086-Feasibility Studies, pubmed-meshheading:20930086-Humans, pubmed-meshheading:20930086-Immunohistochemistry, pubmed-meshheading:20930086-Immunologic Memory, pubmed-meshheading:20930086-Immunophenotyping, pubmed-meshheading:20930086-Immunosuppressive Agents, pubmed-meshheading:20930086-Kidney Failure, Chronic, pubmed-meshheading:20930086-Kidney Transplantation, pubmed-meshheading:20930086-Living Donors, pubmed-meshheading:20930086-Male, pubmed-meshheading:20930086-Mesenchymal Stem Cell Transplantation, pubmed-meshheading:20930086-Pilot Projects, pubmed-meshheading:20930086-T-Lymphocytes, Regulatory, pubmed-meshheading:20930086-Time Factors, pubmed-meshheading:20930086-Transplantation, Autologous, pubmed-meshheading:20930086-Transplantation Conditioning, pubmed-meshheading:20930086-Treatment Outcome, pubmed-meshheading:20930086-Young Adult
pubmed:year	2011
pubmed:articleTitle	Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.
pubmed:affiliation	Transplant Research Center Chiara Cucchi de Alessandri e Gilberto Crespi, Department of Immunology and Transplantation, Ospedali Riuniti di Bergamo, Mario Negri Institute for Pharmacological Research, Centro Anna Maria Astori, Parco Scientifico Tecnologico Kilometro Rosso, via Stezzano 87, 24126 Bergamo, Italy.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't